[1] Chang Y,Li H,Guo Z. Mesenchymal stem cell- like properties in fibroblasts[J].Cell Physiol Biochem,2014,34(3):703-714.
[2] Li J, Huang NF,Zou J, et al. Conversion of human fibroblasts to functional endothelial cells by defined factors[J]. Arterioscler Thromb Vasc Biol,2013,33(6):1366-1375.
[3] Ubil E, Duan J, Pillai IC, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization[J].Nature, 2014, 514(7524):585-590.
[4] Munoz-Chapuli AR, Quesada R, Angel M.Angiogenesis and signal transduction in endothelial cells[J]. Cell Mol Life Sci,2004,61 (17): 2224-2243.
[5] Lamalice, LF, Le B, Huot J. Endothelial cell migration during angiogenesis[J]. Circ Res, 2007,100(6):782-794.
[6] Prasad CK, Krishnan LK. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering[J]. Biomaterials,2005, 26(28):5658-5667.
[7] Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization[J]. Nat Med, 1999,5(4):434-438.
[8] Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease[J]. Circulation, 2004, 109(13):1615-1622.
[9] Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction[J]. Nat Med, 2006,12(4):459-465.
[10] Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice[J]. J Am Coll Cardiol, 2011,58(11):1095-1104.
[11] Dimmeler S, Burchfield J, Zeiher AM. Cell-Based therapy of myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 2008, 28(2):208-216.
[12] Ayvazyan A, Morimoto N, Kanda N, et al. Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs[J]. J Surg Res, 2011, 171(2):247-257.
[13] Florkiewicz RZ, Ahluwalia A, Sandor Z, et al. Gastric mucosal injury activates bFGF gene expression and triggers preferential translation of high molecular weight bFGF isoforms through CUG-initiated, non-canonical codons[J]. Biochem Biophys Res Commun, 2011, 409(3):494-499.
[14] Sun D, Liu Y, Yu Q, et al. The effects of luminescent ruthenium(Ⅱ) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling[J]. Biomaterials, 2013, 34(1):171-180.
[15] Nikolova-Krstevski Ⅴ, Bhasin M, Otu HH, et al. Gene expression analysis of embryonic stem cells expression VE-cadherin(CD144) during endothelial differentiation[J]. BMC Genomics, 2008, 9:240.
[16] Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2008, 16(5):585-601.
[17] Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitrol[J]. Stem Cells, 2004, 22(3): 377-384.
[18] Cho SW, Park HJ, Ryu JH, et al. Vascular patches tissu.e engineered with autologous bone marrow derived cells and decellularized tissue matrices[J]. Biomaterials, 2005, 26(14):1915-1924.
[19] Zhang M, Wang Z, Wang Z, et al. Immobilization of anti-CD31 antibody on electrospun poly (-caprolactone) scaffolds through hydrophobins forspecific adhesion of endothelial cells[J]. Colloids Surf Biointerfaces, 2011,85(1):32-39.
[20] Laouari D, Yang R, Veau C, et al. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure[J]. Am J Physiol Renal Physiol, 2001, 280(4):636-645
[21] Tanaka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody [J].Clin Cancer Res,2001,7(11):3410-3415.
|